Bio
Preeti Jain completed her Ph.D. in animal science from the Central Avian Research Institute, India, in 2009 and holds a master’s degree in biomedical sciences from Bundelkhand University, India. With 14 years of research experience on various infectious diseases at the National Institutes, Preeti has made significant contributions to numerous national health programs. Before joining ACSI India, Preeti was a research officer at the ICMR-National AIDS Research Institute, India.
Drug Discovery
Theranostics: How nuclear medicine is changing precision oncology
Nuclear medicine's theranostics approach enables "see it, treat it" cancer therapy using the same agents for diagnosis and treatment. Investment tripled to $14.86B in 2024 as these precision treatments move to early-stage care.
Drug Discovery
MAIT 细胞是 CAR-T 免疫疗法的未来吗？
与其他类型的非常规 T 细胞相比，MAIT 细胞是一个相对较新的发现，研究人员正在将其用作“现成的”免疫疗法并取得了进展。
.avif)
Drug Discovery
The future of mRNA vaccines beyond COVID-19
COVID-19 was the catalyst for large-scale mRNA vaccine development. Read about how this technology is now on a long-term path of to address a range of challenging diseases.
Safety
New technologies to combat counterfeit drugs
Advanced packaging and on-drug labeling are new technologies to fight counterfeit drugs
Biotechnology
Sensors drive better safety and performance
Science and wearable tech go hand in hand to provide athletes with precise, personalized information to improve their performance.
Emerging Science
猴痘：从科学上讲，我们应该有多担忧？
通过最近关于猴痘的头条新闻，了解更多关于研究布局、科学概况和目前可用的治疗方法的信息。对科学出版物有更深的理解，才能清晰地洞察这一新兴的新闻报道。
Consumer Goods
The latest sports technology innovations enhancing athletic performance
How do science and sportswear fit together? Explore the innovations in fabrics and materials that are creating sportswear that help athletes boost their performance.